logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11672851 B1

PDFFull Text
Date of Patent:
Jun. 13, 2023

Filed:

Dec. 01, 2020

Ny-eso-1-containing artificial adjuvant vector cell for use in treatment of cancer

Applicants:

Astellas Pharma Inc., Tokyo, JP;

Riken, Saitama, JP;

Inventors:

Ayaka Akiba, Tokyo, JP;

Tatsuya Okudaira, Tokyo, JP;

Yasuhide Masuhara, Tokyo, JP;

Keisuke Ohsumi, Tokyo, JP;

Shinichiro Fujii, Saitama, JP;

Assignees:

RIKEN, Saitama, JP;

ASTELLAS PHARMA INC., Tokyo, JP;

Attorney:

Foley & Lardner LLP

Primary Examiner:

Hong Sang

Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/74 (2006.01); C07K 14/705 (2006.01); C12N 5/10 (2006.01); C12N 5/071 (2010.01); A61K 35/00 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001188 (2018.08); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 14/705 (2013.01); C07K 14/70539 (2013.01); C12N 5/0686 (2013.01); C12N 5/10 (2013.01); A61K 2039/5156 (2013.01); C12N 2510/00 (2013.01);
Abstract

An object of the present invention is to provide clinically applicable aAVC-NY-ESO-1 cells stably expressing NY-ESO-1 in order to use aAVC-NY-ESO-1 cells in treating patients having a NY-ESO-1-expressing cancer. The present invention provides, for example, a human-derived cell comprising a polynucleotide encoding CD1d and a polynucleotide encoding NY-ESO-1 or a fragment thereof, wherein the polynucleotide encoding NY-ESO-1 or a fragment thereof is operably linked to an inducible promoter.

Find Patent Forward Citations

Quick Actions:

Akiba, Ayaka. (2023). Ny-eso-1-containing artificial adjuvant vector cell for use in treatment of cancer (U.S. Patent No. 11672851). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11672851

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…